Zone 2 (Europe excluding the EU): Aland Islands (Finland), Andorra, Albania, Armenia, Azerbaijan, Mount Athos (GR), Bosnia-Herzegovina, Campione d'Italia (IT), Ceuta (E), Faroe Islands (DK), Georgia, Gibraltar (GB), Greenland (DK), Guernsey (GB), Iceland, Jersey (GB), Canary Islands (E), Kazakhstan, Kosovo (Serbian province), Liechtenstein, Livigno (IT), Macedonia, Melilla (E), Moldova (Republic ), Montenegro (Republic), Norway, Russian Federation, San Marino, Serbia (Republic), Turkey, Ukraine, Vatican City, Belarus, Cyprus / Republic (North part) Zone 3 (World): Egypt, Algeria, Bahrain, Iran, Iraq, Israel, Yemen, Jordan, Qatar, Kuwait, Lebanon, Libya, Morocco, Oman, Saudi Arabia, Syria, Tunisia, United States, United Arab Emirates Zone 4 (Rest of World): All other countries and areas that are not listeted in zone 1, 2 and 3
[DOI] [PMC free article] [PubMed] [Google Scholar] 43.Zhang Y
Biopolymers
4 Conclusion In conclusion, cancer epigenetics is prevalent in tumors of the digestive, respiratory, female reproductive, and urinary systems, and significant advancements have been made in this field
To date, there has been one phase III RCT for subcutaneous ofatumumab in 35 patients with PV